Radium-223

radium-223 dichloride

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Radium-223, covering 2019-06-11 to 2025-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]

See pricing